Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Long-Term-Liabilities" stands at 62.67 Billion United States Dollars as of 09/30/2025, the highest value since 06/30/2023.
As of the end of Johnson & Johnson's third quarter, the item "Total Long Term Liabilities" stands at 62.67 Billion USD. This represents an increase of 3.18 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 11.18 percent compared to the value the year prior.
The 1 year change in percent is 11.18.
The 3 year change in percent is 13.98.
The 5 year change in percent is -6.98.
The 10 year change in percent is 71.92.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Long Term Liabilities | 905,699,262,464.00 |
![]() | AbbVie Inc - Total Long Term Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Long Term Liabilities | 280,205,508,085.11 |
![]() | Novartis AG - Total Long Term Liabilities | 255,096,620,580.91 |